Last --
Change Today 0.00 / 0.00%
Volume 0.0
2160 On Other Exchanges
Symbol
Exchange
2160 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

gni group ltd (2160) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GNI GROUP LTD (2160)

Related News

No related news articles were found.

gni group ltd (2160) Related Businessweek News

No Related Businessweek News Found

gni group ltd (2160) Details

GNI Group Ltd., a clinical-stage bio-pharmaceutical company, discovers, develops, manufactures, and sells drugs for the treatment of cancer and inflammatory diseases in Asia, primarily in China and Japan. Its products include F647, an oral, low molecular weight compound for the treatment of idiopathic pulmonary fibrosis and radiation pneumonitis, which has completed Phase II human clinical trial; F351, an another oral compound to treat liver fibrosis and cirrhosis, which has completed Phase Ib clinical trial; and F573, a di-peptide small-molecule compound for acute liver failure therapy. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.

123 Employees
Last Reported Date: 03/28/14
Founded in 2001

gni group ltd (2160) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gni group ltd (2160) Key Developments

GNI Group Ltd. to Report Q2, 2014 Results on Aug 14, 2014

GNI Group Ltd. announced that they will report Q2, 2014 results on Aug 14, 2014

GNI Group Ltd. Presents at Emerging Leaders Corporate Day - Hong Kong, Jun-19-2014

GNI Group Ltd. Presents at Emerging Leaders Corporate Day - Hong Kong, Jun-19-2014 . Venue: Mandarin Oriental Hong Kong, Hong Kong, Hong Kong. Speakers: Thomas W. Eastling, Chief Financial Officer, Executive Officer, External Director and Member of Remuneration Committee.

GNI Group Ltd. to Report Q1, 2014 Results on May 15, 2014

GNI Group Ltd. announced that they will report Q1, 2014 results on May 15, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2160:JP ¥400.00 JPY -24.00

2160 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2160.
View Industry Companies
 

Industry Analysis

2160

Industry Average

Valuation 2160 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 226.5x
Price/Book 10.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 194.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GNI GROUP LTD, please visit www.gnipharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.